EC 35 (Atelvia risedronate sodium delayed-release 35 mg)
Generic Name: risedronate
Pill with imprint EC 35 is Yellow, Capsule-shape and has been identified as Atelvia risedronate sodium delayed-release 35 mg. It is supplied by Allergan, Inc.
Atelvia is used in the treatment of osteoporosis and belongs to the drug class bisphosphonates. Risk cannot be ruled out during pregnancy. Atelvia risedronate sodium delayed-release 35 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for EC 35
Atelvia
- Generic Name
- risedronate
- Imprint
- EC 35
- Strength
- risedronate sodium delayed-release 35 mg
- Color
- Yellow
- Size
- 12.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Bisphosphonates
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Allergan, Inc.
- Inactive Ingredients
-
edetate disodium,
ferric oxide yellow,
magnesium stearate,
methacrylic acid - ethyl acrylate copolymer (1:1) type a,
polysorbate 80,
microcrystalline cellulose,
silicon dioxide,
sodium starch glycolate type A potato,
stearic acid,
magnesium silicate,
triethyl citrate
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00430-0979 | Warner Chilcott |
| 00591-3876 (Discontinued) | Watson Pharmaceuticals, Inc. |
Related images for "EC 35"
More about Atelvia (risedronate)
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (3)
- Patient tips
- Drug images
- Pricing & coupons
- Generic availability
- En español
- Drug class: bisphosphonates
- FDA approval history
Patient resources
- Other brands
- Actonel
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.